How Amphastar Pharmaceuticals makes money

Period

FY2025

How does Amphastar Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Amphastar Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31

Revenue$720MGross profit$356M · 49%Cost of revenue$364M · 51%Operating income$140M · 20%Operating expenses$216M · 30%R&D$86M · 12%SG&A$86M · 12%Selling & marketing$44M · 6%Pre-tax income$124M · 17%Other expense$17M · 2%Net income$98M · 14%Income tax$26M · 4%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.